Treatment Of Patients With Social Anxiety Disorder
Status:
Completed
Trial end date:
2007-09-05
Target enrollment:
Participant gender:
Summary
GW876008 is a drug which may change mans reaction to stress, by decreasing the fear, physical
and behavior symptoms that people with SocAD experience in social situations.